28
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Nephrostomy tube versus double J ureteral stent in patients with malignant ureteric obstruction. A systematic review and meta-analysis of comparative studies

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Purpose

          We aimed to perform a systematic review to assess perioperative outcomes, complications, and survival in studies comparing ureteral stent and percutaneous nephrostomy in malignant ureteral obstruction.

          Materials and Methods

          This review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses framework. Meta-analyses were performed on procedural data; outcomes; complications (device-related, accidental dislodgement, febrile episodes, unplanned device replacement), dislodgment, and overall survival. Continuous variables were pooled using the inverse variance of the mean difference (MD) with a fixed effect, and 95% confidence interval (CI). The incidences of complications were pooled using the Cochran-Mantel-Haenszel method with the random effect model and reported as Odds Ratio (OR), and 95% CI. Statistical significance was set two-tail p-value <0.05

          Results

          Ten studies were included. Procedure time (MD −10.26 minutes 95%CI −12.40-8.02, p<0.00001), hospital stay (MD −1.30 days 95%CI −1.69 − −0.92, p<0.0001), number of accidental tube dislodgments (OR 0.25 95% CI 0.13 – 0.48, p<0.0001) were significantly lower in the stent group. No difference was found in mean fluoroscopy time, decrease in creatinine level post procedure, overall number of complications, interval time between the change of tubes, number of febrile episodes after diversion, unplanned device substitution, and overall survival.

          Conclusion

          Our meta-analysis favors stents as the preferred choice as these are easier to maintain and ureteral stent placement should be recommended whenever feasible. If the malignant obstruction precludes a stent placement, then PCN is a safe alternative.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

          Non-randomised studies of the effects of interventions are critical to many areas of healthcare evaluation, but their results may be biased. It is therefore important to understand and appraise their strengths and weaknesses. We developed ROBINS-I (“Risk Of Bias In Non-randomised Studies - of Interventions”), a new tool for evaluating risk of bias in estimates of the comparative effectiveness (harm or benefit) of interventions from studies that did not use randomisation to allocate units (individuals or clusters of individuals) to comparison groups. The tool will be particularly useful to those undertaking systematic reviews that include non-randomised studies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Malignant ureteral obstruction: outcomes after intervention. Have things changed?

            We reviewed the clinical outcome for patients who underwent decompression of malignant ureteral obstruction by analyzing potential prognostic factors, technical success, complication rates and days spent in hospital. Retrospective analysis of 102 patients who underwent decompression for malignant ureteral obstruction from 1991 to 2003 was performed. Data on overall survival, prognostic factors, technical failure, complications and days of hospitalization after decompression were examined. Median overall survival was 6.8 months (95% CI 4.8-9.3) and the overall survival rate at 12 months was 29% (95% CI 21%-39%). Univariate analyses found inferior overall survival associated with patients having metastases (p=0.041), undergoing nephrostomy (p=0.046), prior treatment for cancer (p=0.024) and diagnosis of malignant ureteral obstruction in previously established malignancy (p=0.043). After multivariate analysis poor prognostic factors were presence of metastases (p=0.020) and diagnosis of malignant ureteral obstruction in previously established malignancy (p=0.039). Unfavorable cohorts with 3 or 4 unfavorable baseline risk factors had an inferior overall survival (p=0.008) with 12-month overall survival rates of 12% to 19%. Initial decompression of malignant ureteral obstruction failed in 6% of patients (95% CI 2%-12%) and complications were experienced by 53% (95% CI 43%-63%). Patients were more likely to experience a complication if they had therapy after decompression (p=0.03). The median percentage of their remaining lifetime spent in hospital was 17.4% (range 0.21% to 100%). The overall survival of patients with malignant ureteral obstruction remains poor. Prognostic factors for decreased overall survival and prolonged hospital stay have been identified. Although the technical success of decompression has improved the subsequent complication rate is still high.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?

              To compare the complications and morbidities after placement of a percutaneous nephrostomy (PCN) tube or an internal ureteral stent (IUS) in the management of malignant ureteral obstruction in patients with advanced malignancy. A retrospective analysis was performed on a total of 148 patients (80 women and 68 men, mean age 57.3 years, range 20 to 84) with malignant ureteral obstruction, who underwent PCN tube placement (n = 80) or IUS placement (n = 68) between January 2000 and December 2002. The incidence of fever and acute pyelonephritis was expressed as the number of episodes per 100 person-days. The accumulated incidence of fever and acute pyelonephritis was not different in the two groups. The accumulated incidence and the incidence of febrile episodes in the IUS group was 10.3% and 0.0004/100 person-days; the corresponding values for the PCN group were 15.0% and 0.2154/100 person-days. The incidence of acute pyelonephritis in the IUS and PCN groups was 0.0002/100 person-days and 0.0005/100 person-days, respectively. These patients were treated conservatively and recovered uneventfully. The difference in overall stent-related or catheter-related complications between the IUS and PCN groups was not statistically significant. The accumulated incidence of failed diversion due to obstruction was 11% (8 of 68) and 1.3% (1 of 80) in the IUS and PCN groups, respectively (P = 0.012). Our results have demonstrated that morbidities after internal or external diversion were minimal in cases of malignant obstruction. However, patients scheduled to receive an IUS should be more carefully monitored for ongoing obstruction than patients scheduled for PCN tube placement.
                Bookmark

                Author and article information

                Journal
                Int Braz J Urol
                Int Braz J Urol
                ibju
                International Brazilian Journal of Urology : Official Journal of the Brazilian Society of Urology
                Sociedade Brasileira de Urologia
                1677-5538
                1677-6119
                31 May 2022
                Nov-Dec 2022
                : 48
                : 6
                : 903-914
                Affiliations
                [1 ] orgnameNg Teng Fong General Hospital orgdiv1Department of Urology Singapore Singapore originalDepartment of Urology, Ng Teng Fong General Hospital, Singapore, Singapore
                [2 ] orgnameSan Donato Hospital orgdiv1Department of Urology Arezzo Italy originalDepartment of Urology, San Donato Hospital, Arezzo, Italy
                [3 ] orgnameLe Marche Polytechnic University orgdiv1Faculty of Medicine orgdiv2School of Urology Ancona Italy originalFaculty of Medicine, School of Urology, Le Marche Polytechnic University, Ancona, Italy
                [4 ] orgnameUniversity of Verona orgdiv1Azienda Ospedaliero Universitaria of Verona orgdiv2Department of Urology Verona Italy originalDepartment of Urology, Azienda Ospedaliero Universitaria of Verona, University of Verona, Verona, Italy
                [5 ] orgnameSingapore General Hospital orgdiv1Department of Urology Singapore Singapore originalDepartment of Urology, Singapore General Hospital, Singapore, Singapore
                [6 ] orgnameNational University Hospital orgdiv1Department of Urology Singapore Singapore originalDepartment of Urology, National University Hospital, Singapore, Singapore
                [7 ] orgnameHospital Israelita Albert Einstein São Paulo SP Brasil originalHospital Israelita Albert Einstein, São Paulo, SP, Brasil
                [8 ] orgnameFaculdade de Medicina do ABC Santo André SP Brasil originalFaculdade de Medicina do ABC - FMABC, Santo André, SP, Brasil
                [9 ] orgnameBP – A Beneficência Portuguesa de São Paulo São Paulo SP Brasil originalBP – A Beneficência Portuguesa de São Paulo, São Paulo, SP, Brasil
                [10 ] orgnameUniversity Surgical Cluster orgdiv1National University Hospital orgdiv2Department of Urology Singapore Singapore originalDepartment of Urology, University Surgical Cluster, National University Hospital, Singapore, Singapore
                [11 ] orgnameAzienda Ospedaliero Universitaria Ospedali Riuniti di Ancona orgdiv1Urology Unit Ancona Italy originalUrology Unit, Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona, Italy
                Author notes
                Correspondence address: Daniele Castellani, MD Faculty of Medicine, School of Urology, Le Marche Polytechnic University, Via Conca 71, 60126, Ancona, Italy. Fax: + 39715963367 E-mail: castellanidaniele@ 123456gmail.com

                CONFLICT OF INTEREST

                None declared.

                Author information
                http://orcid.org/0001-7354-9190
                Article
                S1677-5538.IBJU.2022.0225
                10.1590/S1677-5538.IBJU.2022.0225
                9747026
                36037256
                14fdf68e-4ef8-4c74-920a-6202d6a6a900

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 21 April 2022
                : 23 May 2022
                Page count
                Figures: 6, Tables: 1, Equations: 0, References: 27, Pages: 12
                Categories
                Review Article

                ureteral obstruction,nephrostomy, percutaneous,urinary diversion

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content262

                Cited by5

                Most referenced authors399